Fierce Pharma

JANUARY 10, 2024

With a late-stage pipeline spanning more than 120 clinical trials and a firm grasp of five major disease areas, AstraZeneca appears confident heading into 2024. | In AZ's push to reach industry-leading growth by 2030, confidence is key, chief financial officer Aradhana Sarin said at the J.P. Morgan Healthcare Conference. Besides that goal, the company wants to be a top-3 player in its five disease areas of focus.

Leads 311

Leads Healthcare Healthcare 311

MedCity News

JANUARY 10, 2024

In 2023, digital health fundraising took on a bit of a different shape, according to a new Rock Health report. Startups tried out some creative ways to keep their businesses afloat — including series extension rounds, unlabeled fundraises and silent deals from existing investors.

137

137

Fierce Pharma

JANUARY 10, 2024

Age 37 might be old for a “coming-out party,” but that’s the situation for Alkermes at this year’s J.P. Morgan Healthcare Conference, chief operating officer Blair Jackson said in an interview. | Age 37 might be old for a “coming-out party,” but that’s the situation for Alkermes at this year’s J.P. Morgan Healthcare Conference, said chief operating officer Blair Jackson.

Healthcare 285

Healthcare Healthcare 285

MedCity News

JANUARY 10, 2024

A decade after the first recreational marijuana dispensaries opened, will 2024 be the year that cannabis finally gets a get-out-of-jail-for-free card?

Medical 132

Medical 132

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

JANUARY 10, 2024

In his first presentation as the new CEO of BioMarin, Alexander Hardy left no doubt about his mission for the rare and genetic disease specialist. | In his first presentation as the new CEO of BioMarin, Alexander Hardy left no doubt about his mission for the rare and genetic disease specialist. The top priority for the former Genentech CEO is to accelerate and maximize the commercial potential of dwarfism drug Voxzogo.

278

278

PharmExec

JANUARY 10, 2024

Snyder discusses potential trends for various technologies, including AI, digital therapeutics, and virtual reality.

Patients 115

Patients 115

MedCity News

JANUARY 10, 2024

Commons Clinic — a value-based physician group providing musculoskeletal care to patients in the Los Angeles area — announced the launch of its Center for Spine Economics, Outcomes & Research. The center will research and test new models that move spinal care out of the hospital and into community-based accountable care networks. The startup plans to invest $100 million in the center over the next decade.

Physicians 115

Physicians Networking Patients 115

Fierce Pharma

JANUARY 10, 2024

Despite persistent supply hitches since Wegovy’s launch in 2021, Novo Nordisk has quickly garnered blockbuster sales in the newly untapped obesity market. | Despite persistent supply hitches since Wegovy’s launch in 2021, Novo Nordisk has quickly garnered blockbuster sales in the newly untapped obesity market. And to hear Novo’s CEO Lars Fruergaard Jørgensen tell it, the company is "just getting going" in the field.

Sales 246

Sales Marketing 246

pharmaphorum

JANUARY 10, 2024

AbbVie has launched its Produodopa therapy for Parkinson’s disease onto the market in the EU, becoming the first and only 24-hour subcutaneous infusion therapy for the neurodegenerative disorder.

Marketing 115

Marketing 115

MedCity News

JANUARY 10, 2024

Elevance Health will provide smartphones with unlimited data, talk and text to some Medicaid members in 2024, it announced at CES 2024.

113

113

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

pharmaphorum

JANUARY 10, 2024

Precision BioSciences licenses non-cancer uses of its allogeneic CAR-T therapy azer-cel to TG Therapeutics as it pivots to in vivo applications of its gene-editing technology

111

111

MedCity News

JANUARY 10, 2024

Each track will spotlight a different specialty area including: oncology, cardiology, women’s health and preventing burnout/supporting operational efficiency.

Healthcare 110

Healthcare Healthcare Biopharma 110

pharmaphorum

JANUARY 10, 2024

Quantum computing and artificial intelligence specialist SandboxAQ has bought Good Chemistry in a deal focused on drug discovery and material science

105

105

MedCity News

JANUARY 10, 2024

From its heady unicorn days to being newly public to its current financial struggles, the portable ultrasound-on-a-chip company has seen it all. Now, its latest CEO has his work cut out for him. A return to revenue growth is what Joseph DeVivo is promising this year.

Networking 107

Networking 107

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

pharmaphorum

JANUARY 10, 2024

UK study led by Genomics England drawing on 100,000 Genomes Project and real-world clinical data backs use of whole-genome sequencing in cancer care

105

105

European Pharmaceutical Review

JANUARY 10, 2024

A lymph node-targeted cancer vaccine has shown potential to prevent relapse of KRAS-mutated pancreatic and colorectal cancers in patients who have had surgery, according to a Phase I trial led by US researchers. The results were published in Nature Medicine. Results from the cancer vaccine clinical trial In the trial, T cell responses were seen in 84 percent of all patients and in 100 percent of those in the two highest dose cohorts, including those who received the recommended Phase II dose o

Patients 98

Patients Specialization Training Safety 98

pharmaphorum

JANUARY 10, 2024

Spanish pharma Grifols has refuted claims by hedge fund Gotham City that it has manipulated its financial reporting by hiding exposure to debt.

Pharma 100

Pharma 100

PharmaVoice

JANUARY 10, 2024

4DMT’s David Kirn is looking to the future of gene therapy with delivery methods that change the paradigm.

98

98

Advertisement

Pharmaceutical Technology

JANUARY 10, 2024

Vertex Pharmaceuticals has announced the approval of CASGEVY (exagamglogene autotemcel [exa-cel]), the first CRISPR/Cas9 gene-edited therapy.

Pharmaceutical 97

Pharmaceutical 97

PharmaTimes

JANUARY 10, 2024

The partnership will advance VTP-500 from early development to phase 2 clinical trials

95

95

Pharmacy Times

JANUARY 10, 2024

Community pharmacists have a unique opportunity to counsel caregivers on liquid OTC children’s products.

Leads 61

Leads 61

PharmaTimes

JANUARY 10, 2024

The £30m ADVANCE study is the most extensive study into liver disease worldwide

70

70

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

PharmaTech

JANUARY 10, 2024

Nanoform has completed the First Subject First Visit in a trial evaluating the relative bioavailability of its nanotechnology-enhanced enzalutamide.

59

59

Pharmaceutical Technology

JANUARY 10, 2024

The upcoming 14-day pilot study will investigate the safety and response of MP101 in patients with neurogenerative diseases.

Safety 59

Safety Patients 59

PharmaTech

JANUARY 10, 2024

Franco Negron, CEO, Simtra BioPharma Solutions, discusses the company's expertise in supporting the development and manufacture of sterile injectables, its integrated approach to project management, and his expectations regarding the company's future in the industry.

Biopharma 59

Biopharma Manufacturing Management 59

PharmaVoice

JANUARY 10, 2024

Although AI’s failure rates in drug development still leave room for improvement, today’s missteps feed tomorrow’s successes.

59

59

Advertisement

Distribution

Pharmacy Times

JANUARY 10, 2024

The 10-year cumulative incidence rate was equally high between both cohorts of smoking and nonsmoking individuals.

58

58

Scott’s Directories

JANUARY 10, 2024

The healthcare landscape is witnessing new technologies, treatments, and regulations that emerge rapidly. Reaching the right healthcare professionals is crucial for successful campaigns for sales, marketing, and data research teams. However, outdated or inaccurate doctor data can significantly hinder these efforts. MD Select’s Ontario physician directory offers a comprehensive solution to ensure your campaigns remain compliant and achieve maximum impact.

Doctors 52

Doctors Physicians Healthcare Healthcare 52

Pharmacy Times

JANUARY 10, 2024

Claire Biermaas, President of Corporate Partnerships at Cencora, discussed how her team is working with their partners to address new challenges amid the shifting landscape of pharmacy.

55

55

Evolve Your Success

JANUARY 10, 2024

The magic about medical device sales is that anyone can get into the industry no matter the background; all it takes is having passion, commitment, and work ethic. This episode’s guests have the story to inspire you. At just 19 years old, Travis Harvey has created an entirely new life for himself getting into orthopedic medical device sales under Joey Testa.

Sales 52

Sales Medical Medical sales Doctors 52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales